Revised forecast
Fiscal year ending March 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
In the fiscal year ended March 2026, net sales increased due to growth in the number of Melsplan members and expanded sales of daily disposable contact lenses in Japan, as well as increased orders from major mass-retail chains in Europe and North America. Operating income was affected by higher costs for preparations to launch a new plant, wage increases, growth investment, and amortization of goodwill, although selling, general and administrative expenses were appropriately controlled. Ordinary income was attributable to the recognition of foreign exchange gains and other factors. For the fiscal year ending March 2027, the company expects to expand sales and strengthen its supply system, while also factoring in the time required for the Malaysia plant to achieve the benefits of mass production, as well as the effects of foreign exchange movements, the international situation, and resource and energy prices.
Total extraordinary losses: ¥2,181 million. Breakdown: impairment losses, ¥1,903 million; business restructuring expenses, ¥168 million; loss on sale of property, plant and equipment, ¥2 million; loss on retirement of property, plant and equipment, ¥77 million; and other, ¥29 million.
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥133,000 million |
| Operating profit | Not disclosed → ¥11,000 million |
| Ordinary income | Not disclosed → ¥10,500 million |
| Profit attributable to owners of the parent | Not disclosed → ¥6,500 million |
| Net income per share | Not disclosed → 87.58 yen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Previous-period results | Net Sales ¥125,605 million / Operating profit ¥10,236 million / Ordinary income ¥11,021 million / Profit attributable to owners of the parent ¥5,916 million / Net income per share 79.11 yen |
| Reason for the revision | In the fiscal year ended March 2026, net sales increased due to growth in the number of Melsplan members and expanded sales of daily disposable contact lenses in Japan, as well as increased orders from major mass-retail chains in Europe and North America. Operating income was affected by higher costs for preparations to launch a new plant, wage increases, growth investment, and amortization of goodwill, although selling, general and administrative expenses were appropriately controlled. Ordinary income was attributable to the recognition of foreign exchange gains and other factors. For the fiscal year ending March 2027, the company expects to expand sales and strengthen its supply system, while also factoring in the time required for the Malaysia plant to achieve the benefits of mass production, as well as the effects of foreign exchange movements, the international situation, and resource and energy prices. |
| Details and amount of extraordinary loss | Total extraordinary losses: ¥2,181 million. Breakdown: impairment losses, ¥1,903 million; business restructuring expenses, ¥168 million; loss on sale of property, plant and equipment, ¥2 million; loss on retirement of property, plant and equipment, ¥77 million; and other, ¥29 million. |
| Dividend forecast revision | For the fiscal year ending March 2027, an annual dividend of ¥28 per share is planned, consisting of a year-end dividend of ¥28. No indication is provided as to whether the dividend forecast has been revised. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the fiscal year ended March 2026, net sales increased due to growth in the number of members and expanded sales of daily disposable contact lenses in Japan, as well as increased orders from major mass-retail chains in Europe and North America. Operating income was affected by higher costs for preparations to launch a new plant, wage increases, growth investment, and amortization of goodwill, although selling, general and administrative expenses were controlled. Ordinary income was affected by the recognition of foreign exchange gains and other factors, while net income was affected by the recognition of extraordinary losses, including impairment losses. For the fiscal year ending March 2027, the company expects to expand sales and strengthen its supply system, while also factoring in the time required for the Malaysia plant to achieve the benefits of mass production, as well as the effects of foreign exchange movements, the international situation, and resource and energy prices.